| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $106.7M | — | +13.6% |
| Cost of Revenue | $434K | — | -47.8% |
| R&D Expense | $61.1M | — | +8.2% |
| SG&A Expense | $37.9M | — | -5.8% |
| Operating Income | $7.3M | — | +301.3% |
| Interest Expense | $3.1M | — | +0.9% |
| Pre-tax Income | $13.3M | — | +118.1% |
| Income Tax | $301K | — | -71.6% |
| Net Income | $13.0M | — | +158.2% |
| EPS (Basic) | $0.26 | — | +160.0% |
| EPS (Diluted) | $0.25 | — | +150.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $452.7M | -3.2% | -5.1% |
| Short-term Investments | $392.2M | -1.1% | +8.9% |
| Inventory | $8.3M | +22.4% | +21.3% |
| Current Assets | $1.00B | +0.7% | +5.8% |
| Total Assets | $1.07B | +0.5% | +4.3% |
| Current Liabilities | $240.1M | -2.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$13.8M | — | -3266.7% |
| Capital Expenditures | $1.8M | — | +497.7% |
| Investing Cash Flow | $4.2M | — | -56.5% |
| Financing Cash Flow | $656K | — | -74.3% |
| Free Cash Flow | -$15.6M | — | — |
| +61.0% |
| Total Liabilities | $678.4M | -1.1% | +4.4% |
| Stockholders' Equity | $393.7M | +3.3% | +4.0% |